Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'RENAL CELL CANCER' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 176 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Friis, S; Nielsen, GL; Mellemkjaer, L; McLaughlin, JK; Thulstrup, AM; Blot, WJ; Lipworth, L; Vilstrup, H; Olsen, JH
      Cancer risk in persons receiving prescriptions for paracetamol: A Danish cohort study

      INTERNATIONAL JOURNAL OF CANCER
    2. Prescher, A; Brors, D
      Metastases to the paranasal sinuses - Case report and review of the literature.

      LARYNGO-RHINO-OTOLOGIE
    3. Zellweger, T; Miyake, H; July, LV; Akbari, M; Kiyama, S; Gleave, ME
      Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin

      NEOPLASIA
    4. Chehimi, J; Elder, M; Greene, J; Noroski, L; Stiehm, ER; Winkelstein, JA; Sullivan, KE
      Cytokine and chemokine dysregulation in hyper-IgE syndrome

      CLINICAL IMMUNOLOGY
    5. Atkins, MB; Dutcher, J; Weiss, G; Margolin, K; Clark, J; Sosman, J; Logan, T; Aronson, F; Mier, J
      Kidney cancer: The Cytokine Working Group experience (1986-2001) - Part I.IL-2-based clinical trials

      MEDICAL ONCOLOGY
    6. Dutcher, J; Atkins, MB; Margolin, K; Weiss, G; Clark, J; Sosman, J; Logan, T; Aronson, F; Mier, J
      Kidney cancer: The Cytokine Working Group experience (1986-2001) - Part II: Management of IL-2 toxicity and studies with other cytokines

      MEDICAL ONCOLOGY
    7. Dekant, W
      Does exposure to trichloroethene in low doses constitute a cancer risk to humans?

      HUMAN AND ECOLOGICAL RISK ASSESSMENT
    8. Mandel, J; Kelsh, M
      A review of the epidemiology of trichloroethylene and kidney cancer

      HUMAN AND ECOLOGICAL RISK ASSESSMENT
    9. Willhite, CC
      Trichloroethylene carcinogenic potency

      HUMAN AND ECOLOGICAL RISK ASSESSMENT
    10. Bruning, T; Thier, R; Mann, H; Melzer, H; Brode, P; Dallner, G; Bolt, HM
      Pathological excretion patterns of urinary proteins in miners highly exposed to dinitrotoluene

      JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
    11. Zekri, J; Ahmed, N; Coleman, RE; Hancock, BW
      The skeletal metastatic complications of renal cell carcinoma

      INTERNATIONAL JOURNAL OF ONCOLOGY
    12. Wolk, A; Gridley, G; Svensson, M; Nyren, O; McLaughlin, JK; Fraumeni, JF; Adami, HO
      A prospective study of obesity and cancer risk (Sweden)

      CANCER CAUSES & CONTROL
    13. Terry, P; Terry, JB; Wolk, A
      Fruit and vegetable consumption in the prevention of cancer: an update

      JOURNAL OF INTERNAL MEDICINE
    14. Pachucki, J; Ambroziak, M; Tanski, Z; Luczak, J; Nauman, J; Nauman, A
      Type I 5 '-iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    15. Nurminen, M; Karjalainen, A
      Epidemiologic estimate of the proportion of fatalities related to occupational factors in Finland

      SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT & HEALTH
    16. Pavone, L; Andrulli, S; Santi, R; Majori, M; Buzio, C
      Long-term treatment with low doses of interleukin-2 and interferon-alpha: immunological effects in advanced renal cell cancer

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    17. Mickisch, G; Carballido, J; Hellsten, S; Schuize, H; Mensink, H
      Guidelines on renal cell cancer

      EUROPEAN UROLOGY
    18. de Bruijn, DRH; Kater-Baats, E; Eleveld, M; Merkx, G; van Kessel, AG
      Mapping and characterization of the mouse and human SS18 genes, two human SS18-like genes and a mouse Ss18 pseudogene

      CYTOGENETICS AND CELL GENETICS
    19. Siebels, M; Meyer, G; Habicht, A; Meuer, SC; Moebius, U
      Simultaneous ligation of CD5 and CD28 with monoclonal antibodies restores impaired immunostimulatory function in human renal cell carcinoma

      UROLOGICAL RESEARCH
    20. Ruder, AM; Ward, EM; Brown, DP
      Mortality in dry-cleaning workers: An update

      AMERICAN JOURNAL OF INDUSTRIAL MEDICINE
    21. Marusch, F; Koch, A; Dietrich, F; Hoschke, B; Gastinger, I
      A singular late metastasis of renal cell cancer inside the pancreas. An uncommon pancreatic tumor

      ZENTRALBLATT FUR CHIRURGIE
    22. Girgin, C; Tarhan, H; Hekimgil, M; Sezer, A; Gurel, G
      p53 mutations and other prognostic factors of renal cell carcinoma

      UROLOGIA INTERNATIONALIS
    23. Bergstrom, A; Pisani, P; Tenet, V; Wolk, A; Adami, HO
      Overweight as an avoidable cause of cancer in Europe

      INTERNATIONAL JOURNAL OF CANCER
    24. Portielje, JEA; Kruit, WHJ; Eerenberg, AJM; Schuler, M; Sparreboom, A; Lamers, CHJ; Bolhuis, RLH; Stoter, G; Huber, C; Hack, CE
      Interleukin 12 induces activation of fibrinolysis and coagulation in humans

      BRITISH JOURNAL OF HAEMATOLOGY
    25. Tenenbaum, A; Motro, M; Jonas, M; Fisman, EZ; Grossman, E; Boyko, V; Behar, S; Reicher-Reiss, H
      Is diuretic therapy associated with an increased risk of colon cancer?

      AMERICAN JOURNAL OF MEDICINE
    26. Amendola, BE; Wolf, AL; Coy, SR; Amendola, M; Bloch, L
      Brain metastases in renal cell carcinoma: Management with gamma knife radiosurgery

      CANCER JOURNAL
    27. Marroquin, CE; White, DE; Steinberg, SM; Rosenberg, SA; Schwartzentruber, DJ
      Decreased tolerance to interleukin-2 with repeated courses of therapy in patients with metastatic melanoma or renal cell cancer

      JOURNAL OF IMMUNOTHERAPY
    28. Li, Q; Normolle, DP; Sayre, DM; Zeng, XY; Sun, R; Jiang, GH; Redman, B; Chang, AE
      Immunological effects of BCG as an adjuvant in autologous tumor vaccines

      CLINICAL IMMUNOLOGY
    29. Elhilali, MM; Gleave, M; Fradet, Y; Davis, I; Venner, P; Saad, F; Klotz, L; Moore, R; Ernst, S; Paton, V
      Placebo-associated remissions in a multicentre, randomized, double-blind trial of interferon gamma-1b for the treatment of metastatic renal cell carcinoma

      BJU INTERNATIONAL
    30. Hao, D; Huan, SD; Stewart, DJ; Segal, RJ; Yau, JC
      A pilot study of low dose hydroxyurea as a novel resistance modulator in metastatic renal cell cancer

      JOURNAL OF CHEMOTHERAPY
    31. Banks, RE; Forbes, MA; Patel, PM; Storr, M; Hallam, S; Clarke, D; Novick, D; Ingham, E; Bowmer, C; Southgate, J; Trejdosiewicz, LK; Illingworth, J; Perren, TJ; Selby, PJ
      Subcutaneous administration of recombinant glycosylated interleukin 6 in patients with cancer: Pharmacokinetics, pharmacodynamics and immunomodulatory effects

      CYTOKINE
    32. Virtamo, J; Edwards, BK; Virtanen, M; Taylor, PR; Malila, N; Albanes, D; Huttunen, JK; Hartman, AM; Hietanen, P; Maenpaa, H; Koss, L; Nordling, S; Heinonen, OP
      Effects of supplemental alpha-tocopherol and beta-carotene on urinary tract cancer: incidence and mortality in a controlled trial (Finland)

      CANCER CAUSES & CONTROL
    33. Farker, K; Lehmann, MH; Kastner, R; Weber, J; Janitzky, V; Schubert, J; Hoffmann, A
      Analysis of point mutation in exon 2 of CYP2E1 gene in renal cell/urothelial cancer patients in comparison with control population

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    34. Tani, K; Nakazaki, Y; Hase, H; Takahashi, K; Azuma, M; Ohata, J; Kitamura, R; Komine, F; Oiwa, M; Masunaga, A; Maekawa, T; Satoh, N; Adachi, D; Soda, Y; Machida, U; Endo, M; Yamazaki, T; Watari, K; Tojo, A; Yamashita, N; Tomikawa, S; Eriguchi, M; Hamada, H; Wakumoto, Y; Hanazawa, K; Okumura, K; Fujime, M; Shuin, T; Kawai, K; Akaza, H; Clift, S; Ando, D; Sherwin, S; Mulligan, R; Asano, S
      Progress reports on immune gene therapy for stage IV renal cell cancer using lethally irradiated granulocyte-macrophage colony-stimulating factor-transduced autologous renal cancer cells

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    35. Hemmerlein, B; Markus, A; Wehner, M; Kugler, A; Zschunke, F; Radzun, HJ
      Expression of acute and late-stage inflammatory antigens, c-fms, CSF-1, and human monocytic serine esterase 1, in tumor-associated macrophages of renal cell carcinomas

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    36. Schmidinger, M; Steger, GG; Wenzel, C; Locker, GJ; Brodowicz, T; Budinsky, AC; Wiltschke, C; Kramer, G; Marberger, M; Zielinski, CC
      Sequential administration of interferon gamma and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    37. Pacor, S; Magnarin, M; Carotenuto, ME; Spessotto, P; Zabucchi, G; Sava, G
      In vitro growth of TS/A adenocarcinoma and of the gene transfected TS/A-IL4 line on biological substrates

      ANTICANCER RESEARCH
    38. Wartenberg, D; Reyner, D; Scott, CS
      TCE meta-analyses: Response

      ENVIRONMENTAL HEALTH PERSPECTIVES
    39. Pastino, GM; Yap, WY; Carroquino, M
      Human variability and susceptibility to trichloroethylene

      ENVIRONMENTAL HEALTH PERSPECTIVES
    40. Lash, LH; Parker, JC; Scott, CS
      Modes of action of trichloroethylene for kidney tumorigenesis

      ENVIRONMENTAL HEALTH PERSPECTIVES
    41. Bull, RJ
      Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate

      ENVIRONMENTAL HEALTH PERSPECTIVES
    42. Bordin, V; Giani, L; Meregalli, S; Bukovec, R; Vaghi, MM; Mandala, M; Paolorossi, F; Ardizzoia, A; Tancini, G; Barni, S; Frigerio, F; Fumagalli, L; Bordoni, A; Valusani, G; Di Felice, G; Lissoni, P
      Five-year survival results of subcutaneous low-dose immunotherapy with interleukin-2 alone in metastatic renal cell cancer patients

      UROLOGIA INTERNATIONALIS
    43. Ruther, U; Dieckmann, KP; Bussar-Maatz, R; Eisenberger, F
      Second malignancies following pure seminoma

      ONCOLOGY
    44. Chow, WH; Gridley, G; Fraumeni, JF; Jarvholm, B
      Obesity, hypertension, and the risk of kidney cancer in men.

      NEW ENGLAND JOURNAL OF MEDICINE
    45. Schwaab, T; Heaney, JA; Schned, AR; Harris, RD; Cole, BF; Noelle, RJ; Phillips, DM; Stempkowski, L; Ernstoff, MS
      A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha 2b therapy in patients with metastatic renal cell carcinoma: Clinical outcome and analysis of immunological parameters

      JOURNAL OF UROLOGY
    46. Barrett, J; Childs, R
      Non-myeloablative stem cell transplants

      BRITISH JOURNAL OF HAEMATOLOGY
    47. Allen, MJ; Vaughan, M; Webb, A; Johnston, S; Savage, P; Eisen, T; Bate, S; Moore, J; Ahern, R; Gore, ME
      Protracted venous infusion 5-fluorouracil in combination with subcutaneousinterleukin-2 and alpha interferon in patients with metastatic renal cell cancer: a phase II study

      BRITISH JOURNAL OF CANCER
    48. Galbavy, S; Turecky, L; Zlatos, L; Gvozdjakova, A
      Tumorogenic action of streptozotocin on the kidney in female newborn Wistar rats

      BIOLOGIA
    49. Greenberg, A
      Diuretic complications

      AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    50. Mydlo, JH; Kanter, JL; Kral, JG; Macchia, RJ
      The role of obesity and diet in urological carcinogenesis

      BJU INTERNATIONAL
    51. Trinder, P; Seitzer, U; Gerdes, J; Seliger, B; Maeurer, M
      Constitutive and IFN-gamma regulated expression of IL-7 and IL-15 in humanrenal cell cancer

      INTERNATIONAL JOURNAL OF ONCOLOGY
    52. Bruning, T; Mann, H; Melzer, H; Sundberg, AGM; Bolt, HM
      Pathological excretion patterns of urinary proteins in renal cell cancer patients exposed to trichloroethylene

      OCCUPATIONAL MEDICINE-OXFORD
    53. Mogren, I; Damber, L; Tavelin, B; Hogberg, U
      Characteristics of pregnancy and birth and malignancy in the offspring (Sweden)

      CANCER CAUSES & CONTROL
    54. Lip, GYH; Ferner, RE
      Diuretic therapy for hypertension: a cancer risk?

      JOURNAL OF HUMAN HYPERTENSION
    55. Mason, RP
      Calcium channel blockers, apoptosis and cancer: Is there a biologic relationship?

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    56. Menzel, T; Bergmann, L
      Treatment strategies in metastatic renal cell carcinoma

      ONKOLOGIE
    57. Bex, A; Geis, C; Metz, K; Kasimir-Bauer, S; Scheulen, ME; Otto, T; Rubben, H
      Expression of heat shock proteins 27 and 70 in renal cell cancer and normal renal tissue: An immunohistochemical study

      ONKOLOGIE
    58. Bruning, T; Sundberg, AGM; Birner, G; Lammert, M; Bolt, HM; Appelkvist, EL; Nilsson, R; Dallner, G
      Glutathione transferase alpha as a marker for tubular damage after trichloroethylene exposure

      ARCHIVES OF TOXICOLOGY
    59. Machtens, S; Kuczyk, M; Becker, AJ; Bokemeyer, C; Serth, J; Jonas, U
      New aspects on the identification of genetic alterations and prognostically important biological parameters in renal cell cancer

      UROLOGE-AUSGABE A
    60. Kuczyk, M; Munch, T; Machtens, S; Wunning, T; Grunewald, V; Stief, CG; Hofner, K; Jonas, U
      Therapy for kidney cell carcinoma with cava thrombus. Importancy of extracorporeal circulation and prognostic value of cranial tumor extension

      UROLOGE-AUSGABE A
    61. Blom, JHM; van Poppel, H; Marechal, JM; Jacqmin, D; Sylvester, R; Schroder, FH; de Prijck, L
      Radical nephrectomy with and without lymph node dissection: Preliminary results of the EORTC randomized phase III protocol 30881

      EUROPEAN UROLOGY
    62. Hirano, Y; Ushiyama, T; Suzuki, K; Fujita, K
      Clinical application of an in vitro chemosensitivity test, the Histoculture Drug Response Assay, to urological cancers: wide distribution of inhibition rates in bladder cancer and renal cell cancer

      UROLOGICAL RESEARCH
    63. Patterson, LH; McKeown, SR; Robson, T; Gallagher, R; Raleigh, SM; Orr, S
      Antitumour prodrug development using cytochrome P450 (CYP) mediated activation

      ANTI-CANCER DRUG DESIGN
    64. Kroger, MJ; Menzel, TH; Gschwend, JE; Bergmann, L
      Life quality of patients with metastatic renal cell carcinoma and chemo-immunotherapy - A pilot study

      ANTICANCER RESEARCH
    65. Strohmeyer, D
      Pathophysiology of tumor angiogenesis and its relevance in renal cell cancer

      ANTICANCER RESEARCH
    66. Strohmaier, WL
      New treatment modalities - The urologist's view

      ANTICANCER RESEARCH
    67. Becker, G; Duffner, F; Kortmann, R; Weinmann, M; Grote, EH; Bamberg, M
      Radiosurgery for the treatment of brain metastases in renal cell carcinoma

      ANTICANCER RESEARCH
    68. Murata, J; Sawamura, Y; Terasaka, S; Saito, H; Abe, H
      Complete response of a large brain metastasis of renal cell cancer to interferon-alpha: Case report

      SURGICAL NEUROLOGY
    69. Bisignani, GJ; McLaughlin, PJ; Ordille, SD; Beltz, MS; Jarowenko, MV; Zagon, IS
      Human renal cell cancer proliferation in tissue culture is tonically inhibited by opioid growth factor

      JOURNAL OF UROLOGY
    70. Robert, J
      Multidrug resistance in oncology: diagnostic and therapeutic approaches

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    71. Gago-Dominguez, M; Yuan, JM; Castelao, JE; Ross, RK; Yu, MC
      Regular use of analgesics is a risk factor for renal cell carcinoma

      BRITISH JOURNAL OF CANCER
    72. Kimura, M; Tomita, Y; Imai, T; Saito, T; Katagiri, A; Tanikawa, T; Takeda, M; Takahashi, K
      Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients

      BRITISH JOURNAL OF CANCER
    73. Wu, JJ; Caliendo, G; Hu, XP; Dutcher, JP
      Impact of histology on the treatment outcome of metastatic or recurrent renal cell carcinoma

      MEDICAL ONCOLOGY
    74. GOHRING B; HOLZHAUSEN HJ; MEYE A; HEYNEMANN H; REBMANN U; LANGNER J; RIEMANN D
      ENDOPEPTIDASE-24.11 CD10 IS DOWN-REGULATED IN RENAL-CELL CANCER

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    75. LEE DS; WHITE DE; HURST R; ROSENBERG SA; YANG JC
      PATTERNS OF RELAPSE AND RESPONSE TO RETREATMENT IN PATIENTS WITH METASTATIC MELANOMA OR RENAL-CELL CARCINOMA WHO RESPONDED TO INTERLEUKIN-2-BASED IMMUNOTHERAPY

      The cancer journal from Scientific American
    76. PUKKALA E
      CANCER INCIDENCE AMONG FINNISH OIL REFINERY WORKERS, 1971-1994

      Journal of occupational and environmental medicine
    77. NICHOLAS JS; LACKLAND DT; DOSEMECI M; MOHR LC; DUNBAR JB; GROSCHE B; HOEL DG
      MORTALITY AMONG US COMMERCIAL PILOTS AND NAVIGATORS

      Journal of occupational and environmental medicine
    78. CAIRNS P; EVRON E; OKAMI K; HALACHMI N; ESTELLER M; HERMAN JG; BOSE S; WANG SI; PARSONS R; SIDRANSKY D
      POINT MUTATION AND HOMOZYGOUS DELETION OF PTEN MMAC1 IN PRIMARY BLADDER CANCERS/

      Oncogene
    79. FARKER K; LEHMANN MH; KASTNER R; HOFFMANN A; JANITZKY V; SCHUBERT J; MATZ U; HOFMANN W
      CYP2E1 GENOTYPING IN RENAL-CELL UROTHELIAL CANCER-PATIENTS IN COMPARISON WITH CONTROL POPULATIONS

      International journal of clinical pharmacology and therapeutics
    80. FARKER K; LEHMANN MH; OELSCHLAGEL B; HAERTING J; HOFFMANN A; JANITZKY V; SCHUBERT J
      IMPACT OF CYP2E1 GENOTYPE IN RENAL-CELL AND UROTHELIAL CANCER-PATIENTS

      Experimental and toxicologic pathology
    81. JONAS M; GOLDBOURT U; BOYKO V; MANDELZWEIG L; BEHAR S; REICHERREISS H
      NIFEDIPINE AND CANCER MORTALITY - 10-YEAR FOLLOW-UP OF 2607 PATIENTS AFTER ACUTE MYOCARDIAL-INFARCTION

      Cardiovascular drugs and therapy
    82. KUCZYK MA; KOHN G; HOFNER K; MACHTENS S; BOKEMEYER C; STIEF CG; TRUSS MC; SCHAFERS HJ; HARTMANN JT; JONAS U
      PROGNOSTIC VALUE OF INTRACAVAL NEOPLASTIC EXTENSION FOR PATIENTS WITHRENAL-CELL CANCER

      Der Urologe
    83. NOGUCHI S; SHUIN T; KUBOTA Y; WATANABE S; NAGASHIMA Y; MASUDA M; YAO M; HOSAKA M
      HIGH ALKALINE-PHOSPHATASE ACTIVITY IN 3P-INDUCED HUMAN RENAL-CANCER CELLS

      Cancer letters
    84. TOMITA Y; IMAI T; TANIKAWA T; MIZUSAWA T; KANAI T; TAKAHASHI K
      TREATMENT OF BILATERAL RENAL-CELL CANCER AND MULTIPLE LUNG METASTASIS- NEPHRON-SPARING SURGERY AND RESECTION OF LUNG-TUMORS AFTER INTERLEUKIN-2 THERAPY

      European urology
    85. CREAGAN ET; VEEDER MH; SUMAN VJ; BURCH PA; MAPLES WJ; SCHAEFER PL; PFEIFLE DM; DALTON RJ; HATFIELD AK; POON MA
      A PHASE-II STUDY OF HIGH-DOSE CIMETIDINE AND THE COMBINATION 5-FLUOROURACIL, INTERFERON ALPHA-2A, AND LEUCOVORIN IN ADVANCED RENAL-CELL ADENOCARCINOMA

      American journal of clinical oncology
    86. CREAGAN ET; HESTORRF RD; SUMAN VJ; MAILLIARD JA; NAIR S; KROOK JE; KUGLER JW; MARSCHKE RF; MICHALAK JC; TSCHETTER LK
      COMBINED LEVAMISOLE WITH RECOMBINANT INTERLEUKIN-2 (IL-2) IN PATIENTSWITH ADVANCED RENAL-CELL CARCINOMA - A PHASE-II STUDY

      American journal of clinical oncology
    87. BILIM VN; KAWASAKI T; TAKAHASHI K; TOMITA Y
      ABSENCE OF FRAMESHIFT MUTATIONS IN THE BAX GENE IN RENAL-CELL CANCER (RCC) AND TRANSITIONAL-CELL CANCER (TCC)

      Anticancer research
    88. FRAME LT; HART RW; LEAKEY JEA
      CALORIC RESTRICTION AS A MECHANISM MEDIATING RESISTANCE TO ENVIRONMENTAL DISEASE

      Environmental health perspectives
    89. PECTASIDES D; VARTHALITIS J; KOSTOPOULOU M; MYLONAKIS A; TRIANTAPHYLLIS D; PAPADOPOULOU M; DIMITRIADIS M; ATHANASSIOU A
      AN OUTPATIENT PHASE-II STUDY OF SUBCUTANEOUS INTERLEUKIN-2 AND INTERFERON-ALPHA-2B IN COMBINATION WITH INTRAVENOUS VINBLASTINE IN METASTATIC RENAL-CELL CANCER

      Oncology
    90. Makarewicz, R; Zarzycka, M; Kulinska, G; Windorbska, W
      The value of postoperative radiotherapy in advanced renal cell cancer

      NEOPLASMA
    91. Logan, TF; Banner, B; Rao, U; Ernstoff, MS; Wolmark, N; Whiteside, TL; Miketic, L; Kirkwood, JM
      Inflammatory cell infiltrate in a responding metastatic nodule after vaccine-based immunotherapy

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    92. KAMMULA US; WHITE DE; ROSENBERG SA
      TRENDS IN THE SAFETY OF HIGH-DOSE BOLUS INTERLEUKIN-2 ADMINISTRATION IN PATIENTS WITH METASTATIC CANCER

      Cancer
    93. DESTEFANI E; FIERRO L; MENDILAHARSU M; RONCO A; LARRINAGA MT; BALBI JC; ALONSO S; DENEOPELLEGRINI H
      MEAT INTAKE, MATE DRINKING AND RENAL-CELL CANCER IN URUGUAY - A CASE-CONTROL STUDY

      British Journal of Cancer
    94. VANFOSSEN VL; EDIS AJ; POLLARD JA
      RENAL-CELL CARCINOMA METASTATIC TO THE THYROID

      Australian and New Zealand journal of surgery
    95. Terada, N; Hiruma, K; Suzuki, M; Numata, T; Konno, A
      Metastasis of renal cell cancer to the ethmoid sinus

      ACTA OTO-LARYNGOLOGICA
    96. DUTCHER JP; ATKINS M; FISHER R; WEISS G; MARGOLIN K; ARONSON F; SOSMAN J; LOTZE M; GORDON M; LOGAN T; MIER J
      INTERLEUKIN-2-BASED THERAPY FOR METASTATIC RENAL-CELL CANCER - THE CYTOKINE WORKING GROUP EXPERIENCE, 1989-1997

      The cancer journal from Scientific American
    97. CORMIER JN; HURST R; VASSELLI J; LEE D; KIM CJ; MCKEE M; VENZON D; WHITE D; MARINCOLA FM; ROSENBERG SA
      A PROSPECTIVE RANDOMIZED EVALUATION OF THE PROPHYLACTIC USE OF LOW-DOSE DOPAMINE IN CANCER-PATIENTS RECEIVING INTERLEUKIN-2

      Journal of immunotherapy with emphasis on tumor immunology
    98. GUIDA M; LATORRE A; SELVAGGI FP; DITONNO P; LORUSSO V; MASTRIA A; DELENA M
      SUBCUTANEOUS RECOMBINANT INTERLEUKIN-2 PLUS ALPHA-INTERFERON AND VINBLASTINE IN METASTATIC RENAL-CELL CARCINOMA - A PHASE-II STUDY

      International journal of oncology
    99. LYNGE E; ANTTILA A; HEMMINKI K
      ORGANIC-SOLVENTS AND CANCER

      CCC. Cancer causes & control
    100. BOFFETTA P; JOURENKOVA N; GUSTAVSSON P
      CANCER RISK FROM OCCUPATIONAL AND ENVIRONMENTAL EXPOSURE TO POLYCYCLIC AROMATIC-HYDROCARBONS

      CCC. Cancer causes & control


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/06/20 alle ore 02:57:03